Neuropsychopharmacology - Table of Contents alert Volume 41 Issue 4

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 41, Issue 4 (March 2016) In this issue Commentary Original Articles Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? In this new podcast from Neuropsychopharmacology, Drs. Margaret Haney and Eden Evins discuss the relationship between cannabis use and two psychiatric disorders: post-traumatic stress disorder and psychotic illnesses, particularly schizophrenia. Click here to listen   Commentary Top Women at the Podium: ACNP Strives to Reach Speaker Gender Equality at the Annual Meeting Bita Moghaddam and Raquel E Gur Neuropsychopharmacology 2016 41: 929-931; advance online publication, November 11, 2015; 10.1038/npp.2015.320 Full Text Original Articles Top Oxytocin Facilitates Pavlovian Fear Learning in Males Monika Eckstein, Dirk Scheele, Alexandra Patin, Katrin Preckel, Benjamin Becker, Annika Walter, Katharina Domschke, Valery Grinevich, Wolfgang Maier and René Hurlemann Neuropsychopharmacology 2016 41: 932-939; advance online publication, August 14, 2015; 10.1038/npp.2015.245 Abstract | Full Text Biases in the Explore–Exploit Tradeoff in Addictions: The Role of Avoidance of Uncertainty OPEN Laurel S Morris, Kwangyeol Baek, Prantik Kundu, Neil A Harrison, Michael J Frank and Valerie Voon Neuropsychopharmacology 2016 41: 940-948; advance online publication, July 15, 2015; 10.1038/npp.2015.208 Abstract | Full Text Neuroimmune Regulation of GABAergic Neurons Within the Ventral Tegmental Area During Withdrawal from Chronic Morphine OPEN Anna M W Taylor, Annie Castonguay, Atefeh Ghogha, Pia Vayssiere, Amynah A A Pradhan, Lihua Xue, Sadaf Mehrabani, Juli Wu, Pat Levitt, Mary C Olmstead, Yves De Koninck, Christopher J Evans and Catherine M Cahill Neuropsychopharmacology 2016 41: 949-959; advance online publication, July 23, 2015; 10.1038/npp.2015.221 Abstract | Full Text GABA-Mediated Inactivation of Medial Prefrontal and Agranular Insular Cortex in the Rat: Contrasting Effects on Hunger- and Palatability-Driven Feeding Brian A Baldo, Robert C Spencer, Ken Sadeghian and Jesus D Mena Neuropsychopharmacology 2016 41: 960-970; advance online publication, July 23, 2015; 10.1038/npp.2015.222 Abstract | Full Text Dopamine D2-Like Receptors and Behavioral Economics of Food Reinforcement Paul L Soto, Takato Hiranita, Ming Xu, Steven R Hursh, David K Grandy and Jonathan L Katz Neuropsychopharmacology 2016 41: 971-978; advance online publication, July 24, 2015; 10.1038/npp.2015.223 Abstract | Full Text The Calpain Inhibitor A-705253 Attenuates Alcohol-Seeking and Relapse with Low Side-Effect Profile Valentina Vengeliene, Achim Moeller, Marcus W Meinhardt, Patrick M Beardsley, Wolfgang H Sommer, Rainer Spanagel and Anton Bespalov Neuropsychopharmacology 2016 41: 979-988; advance online publication, July 28, 2015; 10.1038/npp.2015.225 Abstract | Full Text Relative Timing Between Kappa Opioid Receptor Activation and Cocaine Determines the Impact on Reward and Dopamine Release Elena H Chartoff, Shayla R Ebner, Angela Sparrow, David Potter, Phillip M Baker, Michael E Ragozzino and Mitchell F Roitman Neuropsychopharmacology 2016 41: 989-1002; advance online publication, August 4, 2015; 10.1038/npp.2015.226 Abstract | Full Text Optogenetic Activation of Adenosine A2A Receptor Signaling in the Dorsomedial Striatopallidal Neurons Suppresses Goal-Directed Behavior Yan Li, Yan He, Mozi Chen, Zhilan Pu, Li Chen, Ping Li, Bo Li, Haiyan Li, Zhi-Li Huang, Zhihui Li and Jiang-Fan Chen Neuropsychopharmacology 2016 41: 1003-1013; advance online publication, July 28, 2015; 10.1038/npp.2015.227 Abstract | Full Text Chemogenetic Inactivation of Dorsal Anterior Cingulate Cortex Neurons Disrupts Attentional Behavior in Mouse Hiroyuki Koike, Michael P Demars, Jennifer A Short, Elisa M Nabel, Schahram Akbarian, Mark G Baxter and Hirofumi Morishita Neuropsychopharmacology 2016 41: 1014-1023; advance online publication, July 30, 2015; 10.1038/npp.2015.229 Abstract | Full Text Reciprocal Inhibitory Interactions Between the Reward-Related Effects of Leptin and Cocaine Zhi-Bing You, Bin Wang, Qing-Rong Liu, Yan Wu, Laszlo Otvos and Roy A Wise Neuropsychopharmacology 2016 41: 1024-1033; advance online publication, August 5, 2015; 10.1038/npp.2015.230 Abstract | Full Text CFH Variants Affect Structural and Functional Brain Changes and Genetic Risk of Alzheimer’s Disease Deng-Feng Zhang, Jin Li, Huan Wu, Yue Cui, Rui Bi, He-Jiang Zhou, Hui-Zhen Wang, Chen Zhang, Dong Wang, Alzheimer's Disease Neuroimaging Initiative (ADNI), Qing-Peng Kong, Tao Li, Yiru Fang, Tianzi Jiang and Yong-Gang Yao Neuropsychopharmacology 2016 41: 1034-1045; advance online publication, August 5, 2015; 10.1038/npp.2015.232 Abstract | Full Text The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN Kenichi Fukumoto, Michihiko Iijima and Shigeyuki Chaki Neuropsychopharmacology 2016 41: 1046-1056; advance online publication, August 6, 2015; 10.1038/npp.2015.233 Abstract | Full Text Sex-Steroid Hormone Manipulation Reduces Brain Response to Reward Julian Macoveanu, Susanne Henningsson, Anja Pinborg, Peter Jensen, Gitte M Knudsen, Vibe G Frokjaer and Hartwig R Siebner Neuropsychopharmacology 2016 41: 1057-1065; advance online publication, August 6, 2015; 10.1038/npp.2015.236 Abstract | Full Text Cannabinoids and Glucocorticoids in the Basolateral Amygdala Modulate Hippocampal–Accumbens Plasticity After Stress Amir Segev and Irit Akirav Neuropsychopharmacology 2016 41: 1066-1079; advance online publication, August 20, 2015; 10.1038/npp.2015.238 Abstract | Full Text Specific Inhibition of Phosphodiesterase-4B Results in Anxiolysis and Facilitates Memory Acquisition Alexander McGirr, Tatiana V Lipina, Ho-Suk Mun, John Georgiou, Ahmed H Al-Amri, Enoch Ng, Dongxu Zhai, Christina Elliott, Ryan T Cameron, Jonathan GL Mullins, Fang Liu, George S Baillie, Steven J Clapcote and John C Roder Neuropsychopharmacology 2016 41: 1080-1092; advance online publication, August 14, 2015; 10.1038/npp.2015.240 Abstract | Full Text 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder Pedro E Martinez, David R Rubinow, Lynnette K Nieman, Deloris E Koziol, A Leslie Morrow, Crystal E Schiller, Dahima Cintron, Karla D Thompson, Khursheed K Khine and Peter J Schmidt Neuropsychopharmacology 2016 41: 1093-1102; advance online publication, August 14, 2013; 10.1038/npp.2015.246 Abstract | Full Text Bidirectional Modulation of Alcohol-Associated Memory Reconsolidation through Manipulation of Adrenergic Signaling Moritz J W Schramm, Barry J Everitt and Amy L Milton Neuropsychopharmacology 2016 41: 1103-1111; advance online publication, August 17, 2015; 10.1038/npp.2015.248 Abstract | Full Text Chronic Intermittent Ethanol Exposure Enhances the Excitability and Synaptic Plasticity of Lateral Orbitofrontal Cortex Neurons and Induces a Tolerance to the Acute Inhibitory Actions of Ethanol Sudarat Nimitvilai, Marcelo F Lopez, Patrick J Mulholland and John J Woodward Neuropsychopharmacology 2016 41: 1112-1127; advance online publication, August 9, 2015; 10.1038/npp.2015.250 Abstract | Full Text Corticostriatal Afferents Modulate Responsiveness to Psychostimulant Drugs and Drug-Associated Stimuli K A Kerstetter, A M Wunsch, K G Nakata, E Donckels, J F Neumaier and Susan M Ferguson Neuropsychopharmacology 2016 41: 1128-1137; advance online publication, August 20, 2015; 10.1038/npp.2015.253 Abstract | Full Text Stratifying Risk for Renal Insufficiency Among Lithium-Treated Patients: An Electronic Health Record Study Victor M Castro, Ashlee M Roberson, Thomas H McCoy, Anna Wiste, Andrew Cagan, Jordan W Smoller, Jerrold F Rosenbaum, Michael Ostacher and Roy H Perlis Neuropsychopharmacology 2016 41: 1138-1143; advance online publication, August 21, 2015; 10.1038/npp.2015.254 Abstract | Full Text The Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems Gregory S Parks, Deepti R Warrier, Lars Dittrich, Michael D Schwartz, Jeremiah B Palmerston, Thomas C Neylan, Stephen R Morairty and Thomas S Kilduff Neuropsychopharmacology 2016 41: 1144-1155; advance online publication, August 20, 2015; 10.1038/npp.2015.256 Abstract | Full Text Predicting Treatment Outcome in PTSD: A Longitudinal Functional MRI Study on Trauma-Unrelated Emotional Processing Sanne J H van Rooij, Mitzy Kennis, Matthijs Vink and Elbert Geuze Neuropsychopharmacology 2016 41: 1156-1165; advance online publication, August 20, 2015; 10.1038/npp.2015.257 Abstract | Full Text Partial mGlu5 Negative Allosteric Modulators Attenuate Cocaine-Mediated Behaviors and Lack Psychotomimetic-Like Effects Robert W Gould, Russell J Amato, Michael Bubser, Max E Joffe, Michael T Nedelcovych, Analisa D Thompson, Hilary H Nickols, Johannes P Yuh, Xiaoyan Zhan, Andrew S Felts, Alice L Rodriguez, Ryan D Morrison, Frank W Byers, Jerri M Rook, John S Daniels, Colleen M Niswender, P Jeffrey Conn, Kyle A Emmitte, Craig W Lindsley and Carrie K Jones Neuropsychopharmacology 2016 41: 1166-1178; advance online publication, August 28, 2015; 10.1038/npp.2015.265 Abstract | Full Text Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence Isabelle Boileau, Tina McCluskey, Junchao Tong, Yoshiaki Furukawa, Sylvain Houle and Stephen J Kish Neuropsychopharmacology 2016 41: 1179-1187; advance online publication, August 31, 2015; 10.1038/npp.2015.267 Abstract | Full Text Corrigendum Top Functional Uncoupling NMDAR NR2A Subunit from PSD-95 in the Prefrontal Cortex: Effects on Behavioral Dysfunction and Parvalbumin Loss after Early-Life Stress Prabarna Ganguly, Freedom H Holland and Heather C Brenhouse Neuropsychopharmacology 2016 41: 1188; 10.1038/npp.2015.334 Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.